Table 1.
Evaluation measures | |
---|---|
Patient demographics | Age, sex, handedness, stroke etiology (i.e. ischemic vs hemorrhagic, location of stroke lesion, etc.), primary stroke treatment (i.e. medications, surgical procedures, etc.), starting date of rehabilitation, duration of HAL treatment, number of HAL treatment sessions |
Stroke severity assessment | Glasgow coma scale (GCS), modified rankin scale (mRS), national institute of health stroke scale (NIHSS), stroke impairment assessment set (SIAS) |
Motor function | Fugl-Meyer assessment (FMA), 10-m walking test (10MWT), 2-minute walk test, action research arm test (ARAT), Berg balance scale (BBS) |
Activities of daily living | Barthel index (BI), functional independence measure (FIM) |
Quality of life | SF-36 |
Cognition | Mini-mental status exam (MMSE), Motreal cognitive assessment (MoCA) |
Mood | Apathy scale, self-rating depression scale (SDS) |
Others | Modified Ashworth scale (for spasticity assessment), adverse events (for safety assessment), imaging studies including fMRI, DTI, and NIRS |
DTI: diffusion tensor imaging, fMRI: functional magnetic resonance imaging, NIRS: near infrared spectroscopy.